<?xml version="1.0" encoding="UTF-8"?>
<ref id="B101-pharmaceuticals-12-00157">
 <label>101.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Herc√≠k</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kozak</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Sala</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dejmek</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Bei</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Dou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>137</volume>
  <fpage>131</fpage>
  <lpage>133</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2016.11.020</pub-id>
  <pub-id pub-id-type="pmid">27902932</pub-id>
 </element-citation>
</ref>
